Meanwhile, the levels of caspase-3 in osteosarcoma tissues did not demonstrate significant differences in relation to tumor metastasis and patient mortality within a 3-year period (Fig. S1D and S1F). This evidence concerns the gene CASP3 and osteosarcoma.